In detail, under physiological conditions, these isoenzymes modulate the generation of amyloid precursor protein (APP), promoting the α-secretase activity therefore decreasing the production of amyloid-β proteins, which are the main macromolecular structures involved in Alzheimer’s disease. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.